Cargando…
T cell receptor-therapy in HBV-related hepatocellularcarcinoma
Adoptive transfer of lymphocytes expressing engineered T cell receptors (TCR) is a promising option for cancer treatment and could include hepatocellularcarcinoma (HCC), where therapeutic options are limited. We have recently investigated whether hepatitis B viral antigens can act as a HCC-specific...
Autores principales: | Bertoletti, Antonio, Brunetto, Maurizia, Maini, Mala K, Bonino, Ferruccio, Qasim, Waseem, Stauss, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485715/ https://www.ncbi.nlm.nih.gov/pubmed/26155416 http://dx.doi.org/10.1080/2162402X.2015.1008354 |
Ejemplares similares
-
Hepatocellularcarcinoma: current imaging techniques
por: De Luca, S, et al.
Publicado: (2015) -
HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History
por: Bonino, Ferruccio, et al.
Publicado: (2022) -
Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy
por: Colombatto, Piero, et al.
Publicado: (2022) -
Preoperative diagnosis and prediction of microvascular invasion in hepatocellularcarcinoma by ultrasound elastography
por: Xu, Chengchuan, et al.
Publicado: (2022) -
Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine
por: Colombatto, Piero, et al.
Publicado: (2022)